Concepedia

Thomas I. Potgieter

TI

8

Publications

494

Citations

8

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Thomas I. Potgieter is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in glycobiology, biotechnology, and medicine.

Top concepts

Publications per year

2008–2013

8

Publications

8

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 157 citations

, , +4

Optimization of a glycoengineered <i>Pichia pastoris</i> cultivation process for commercial antibody production

Jianxin Ye, Jeffrey Ly, K. Shawn Watts et al. · Biotechnology Progress · 2011 · 68 citations

Antibody expression kinetics in glycoengineered <i>Pichia pastoris</i>

Thomas I. Potgieter, Sean D. Kersey, Muralidhar Mallem et al. · Biotechnology and Bioengineering · 2010 · 62 citations

, , +17

High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies

Gavin C. Barnard, Angela Kull, Nathan S. Sharkey et al. · Journal of Industrial Microbiology & Biotechnology · 2010 · 58 citations · Full text

Characterization of the Pichia pastoris Protein-O-mannosyltransferase Gene Family

Juergen H. Nett, W. James Cook, Chen Mingtang et al. · PLoS ONE · 2013 · 44 citations · Full text

, , +17

Rows per page

1–5 of 8